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Angelica Ronald
It is common, particularly in young people, to report psychotic
experiences (PEs) such as feeling paranoid and having
hallucinations. The questions of the role of genes and
environment on PEs in the general population, and how PEs
relate to schizophrenia, have not, until recently, been
addressed empirically. New approaches demonstrate the
heritability and role of the environment on the full range of PEs
(including positive, cognitive and negative types) and show that
extreme, severe forms are linked genetically to milder, less
severe forms. New approaches have tested whether PEs are
associated with the genome-wide significant genetic variants
known to predict schizophrenia. Although at an early stage, this
research will impact how we understand PEs in everyday life.
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Introduction
This review covers quantitative genetic literature on
psychotic experiences (PEs) over the last four years
(2011–2014). ‘PEs’ are used here to refer to normal traits
in the general population, such as paranoia (see also
schizotypal traits for more personality-based constructs),
that at the extreme are characteristic of symptoms of
psychotic disorders such as schizophrenia [1]. Quantitat-
ive genetic research aims to investigate the genetic and
environmental influences on quantitative phenotypes [2].
PEs are common [3] and are associated with many nega-
tive consequences, including increased risk of suicide
[4,5]. Furthermore, PEs are risk factors for schizophrenia,
a potentially debilitating illness and one of the UK’s most
resource-consuming brain disorders [6]. As such, research
on PEs can not only help us understand PEs themselves,
but may also shed light on the neurodevelopment that
underlies psychotic illness.
Family studies
Family studies can reveal the degree to which PEs are
influenced by familiality, which includes both genetic
and shared environmental effects, for example [7,8]. A
disadvantage is that family studies cannot disentangle the
roles of genes and shared environment. For this reason,
and because of the brief format of this review, family
studies of PEs are not reviewed in full; for a review of
schizotypy in relatives of individuals with schizophrenia,
see [9].
Twin studies
Table 1 reviews twin studies in the last four years on PEs
in the general population. Across all studies, the range of
heritability estimates suggests between a third and a half
of variance in PEs/schizotypy scales is explained by
additive genetic effects in the population (although note
the relatively lower heritability for hallucinations in
males in the most recent and largest study) [10]. The
remaining half-to-two-thirds of the variance in PEs and
schizotypy scales was accounted for by nonshared
environmental effects (which refers to environmental
effects that make children growing up in the same family
different, and includes measurement error). Effects of
shared environment (environmental effects that make
children growing up in the same family similar) were
nonsignificant in all studies, with the exception of mod-
est effects on hallucinations and parent-rated negative
symptoms in one study [10].
Heritability of individual PEs
A new approach has been to investigate the heritability of
the full range of individual positive, cognitive, and nega-
tive PEs assessed quantitatively in the general population
[10]. A recent study, reported in Table 1, demonstrated
that hallucinations are the least heritable PE, particularly
for males (males: 15%, females: 32%) (see also [11]),
whereas negative symptoms and paranoia have compar-
ably higher heritability (59% and 50%, respectively), and
the other types of PEs show estimates in between these
values [10].
Causes of longitudinal stability of PEs
Longitudinal data, available in one study reported in
Table 1, have demonstrated that schizotypal traits are
stable across adolescence and that this stability is
explained by common genetic effects over time [12].
In a further study (not reported in Table 1 because it
did not include twin model-fitting), female adults in the
general population were assessed on PEs three times
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Table 1
Twin studies of dimensional assessments of psychotic experiences and schizotypal traits in community samples published in 2011–2014
(presented reverse chronologically).
Study Measure (name;
number of
items; rater)
Sample (study; N for MZ
and DZ individuals; age;
gender)
Phenotypes (principal
component analysis, subscale
divisions)
Quantitative genetic findings
Zavos et al. (2014)
[10]
Specific Psychotic
Experiences
Questionnaire
(SPEQ) [3]; 63 items;
six subscales;
self-/parent-rated
Twins Early
Development Study;
3395 MZ, 6087 DZ;
age 16; 45% male
Six subscales derived from
principal component analysis
[3]: paranoia, hallucinations,
cognitive disorganisation,
grandiosity, anhedonia (all
self-rated), negative
symptoms (parent-rated)
Univariate. Heritabilities:
paranoia (50%), hallucinations
(males 15%, females 32%),
cognitive disorganisation (43%),
grandiosity (44%), anhedonia
(47%), parent-rated negative
symptoms (59%). C was modest
for hallucinations and negative
symptoms (17–24%) and
nonsignificant for other scales. E
was considerable for all scales
(49–64%) but lower for parent-
rated negative symptoms (17%)
Sex differences. No qualitative
sex differences found; only
hallucinations showed
quantitative sex differences (see
above)
Multivariate. High genetic
correlations (0.61–0.63) and
modest nonshared environment
correlations (.24–.33) observed
between paranoia and
hallucinations, paranoia and
cognitive disorganisation, and
hallucinations and cognitive
disorganisation. Moderate
genetic correlation (.27) and low
nonshared environment
correlation (.10) between
cognitive disorganisation and
negative symptoms. Majority of
covariance explained by genetic
influences (54–71%)
Extremes analysis. See Figure 1
Hur et al. (2012)
[11]
Launay–Slade
Hallucination
Scale-Revised
(LSHS-R) [46];
12 items; self-rated
South Korean Twin
Registry; 802 MZ,
394 DZ; age 12–19
years; 45% male
One Hallucinations scale Hallucinations heritability 33%,
remaining variance explained by
E (67%). No quantitative sex
differences
Ericson et al.
(2011) [12]
Schizotypal Personality
Questionnaire child
version (SPQ-C);
22 items; self-rated
Southern California
Twin Project; wave 2:
182 MZ, 173 DZ, wave
3: 377 MZ, 584 DZ; age
11–13 (wave 2) and 14–
16 (wave 3); 47–48%
male
Three subscales derived from
principal component analysis:
cognitive-perceptual,
interpersonal-affective,
disorganisation
Univariate. Heritabilities at waves
2 and 3: cognitive-perceptual
(53% and 53%, respectively),
interpersonal-affective (46% and
38%, respectively),
disorganisation (42% and 57%,
respectively); remaining variance
explained by E. No significant or
consistent changes from wave
2 to wave 3. Three subscales
loaded onto a separate common
factor at each age, and the two
common factors were stable
(r = .58) and this stability was
mainly explained by genetic
effects (81%)
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across two years. Concordance in identical (or monozy-
gotic, MZ) twins for being in a persistent group (derived
from latent class analysis) was higher than the fraternal
(dizygotic, DZ) twin concordance, suggesting genetic
effects on persistence of PEs over time in adults [13].
As such, available evidence suggests considerable phe-
notypic and genetic stability in PEs.
Heritability of questionnaire versus interview measures
While most twin studies in Table 1 relied on question-
naire data, one study employed trained interviewers to
conduct structured interviews [14]. Heritability of the
symptom counts derived from interviews was similar to
the heritability estimates from the self-report question-
naire data in other studies. Self-report of PEs has been
validated against in-depth clinical interviews but is
known to give higher mean scores than interviews [15].
As such, it is helpful to observe similarities in heritability
estimates across different methods of assessment.
Genetic and environmental overlap between PEs
Multivariate analyses have explored the degree to which
different PEs share genetic and environmental influ-
ences. Whether for individual PEs [10], individual
schizotypal domains [12], or symptom counts from differ-
ent types of personality disorder [14], all studies reported
considerable overlap in genetic effects across different
PEs. For example, in a recent study of adolescents,
paranoia and hallucinations correlated r = .47, and 64%
of this covariation was explained by genetic influences,
and the genetic correlation was high (0.61). Together, the
multivariate results suggest considerable pleiotropic
genetic effects across the different individual types of
PE, together with some genetic effects being specific to
individual PEs. Twin studies can also explore the degree
to which causal influences on PEs are shared with other
forms of psychopathology, cognition, and personality (for
recent findings see [14,16–19]).
Molecular genetic studies
PEs and genes associated with schizophrenia liability
Table 2 outlines the two molecular genetic publications
on PEs in general population samples on genome-wide
identified variants. Overall, both studies, which employed
adolescent samples, found some tentative evidence that
genome-wide significant variants associated with schizo-
phrenia also influence variance in PEs in the community,
as well as several negative results.
One genome-wide significant schizophrenia-associated
risk allele (rs17512836, in TCF4) was significantly associ-
ated with higher quantitative scores on a paranoia scale in
the general population at age 16 [20]. TCF4 (transcrip-
tion factor 4 gene) encodes a basic Helix-Loop-Helix
(bHLH) transcription factor and is highly expressed in
the brain, where it plays a role in neurodevelopment [21].
On the other hand, a second study, which used a categorical
score of presence of at least one definite PE at age 12 or 18,
found no individual schizophrenia-associated variants to be
significantly associated with their measure of PEs [22].
Polygenic risk scores (the weighted sum of the number of
risk alleles carried by an individual [23]) were also
employed in both studies in Table 2. Schizophrenia
and bipolar disorder polygenic risk scores did not signifi-
cantly predict any of six quantitative PE subscales at age
16 [20] (scores were derived from the Psychiatric Geno-
mics Consortium (PGC) stage-1 mega-analysis). The
same schizophrenia polygenic risk score was investigated
in the second study and did not predict the presence of at
least one definite PE at either age 12 or 18 [22]. Notably,
individuals who had at least one definite PE had on
average higher schizophrenia polygenic risk scores than
those who had not had at least one PE [22].
In sum, both studies provide some evidence for a genetic
link between PEs in adolescence and diagnosed schizo-
phrenia, but both studies also report negative findings. To
Quantitative genetic research on psychotic experiences Ronald 83
Table 1 (Continued )
Study Measure (name;
number of
items; rater)
Sample (study; N for MZ
and DZ individuals; age;
gender)
Phenotypes (principal
component analysis, subscale
divisions)
Quantitative genetic findings
Kendler et al.
(2011) [14]
Structured interview for
DSM-IV personality
(SIDP-IV);
semi-structured
diagnostic interview by
trained interviewer
(over 92% face-to-face;
8% by telephone)
Norwegian Institute for
Public Health Twin
Panel; 1338 MZ and
754 DZ pairs; mean age
28.2 years (SD 3.9);
36.5% male
Ordinal counts of number of
positively endorsed criteria for
paranoid personality disorder,
schizoid personality disorder
and schizotypal personality
disorder
Univariate. Heritabilities of ordinal
counts of endorsed criteria for
paranoid personality disorder
(29%), schizoid personality
disorder (34%) and schizotypal
personality disorder (38%).
Remaining variance explained by
E
Multivariate. All three scales
loaded onto genetic factor
labelled ‘Axis-II Internalising’
Note: MZ, monozygotic twins; DZ, dizygotic twins. C, shared environmental effects; E, nonshared environmental effects. Only twin studies that reported
structural equation twin model-fitting included.
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take these findings forward, research needs to continue with
larger samples and with more reliable polygenic risk scores,
as well as to find ways to tackle the phenotypic heterogen-
eity inherent in the schizophrenia risk score. Schizophrenia
has no universal symptom, and therefore when considering
the link between a specific PE, such as hallucinations, and
clinical schizophrenia, not all individuals with clinical
schizophrenia will have the specific experience. Schizo-
phrenia is also often characterised by social dysfunction,
which is not captured by many existing measures of PEs.
Genome-wide association studies
In terms of systematic gene-discovery work, so far there
is one genome-wide association study of PEs. With
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Table 2
Molecular genetic research on psychotic experiences in community or general population samples published in 2011–2014 on genome-
wide identified variants (see text for candidate gene studies) (presented reverse chronologically).
Study Phenotype measure (name;
number of items; rater)
Sample (study; N
individuals; age; gender)
Analyses Findings
Sieradzka et al.
(2014) [20]
Specific Psychotic
Experiences Questionnaire
(SPEQ) [3]; 63 items; six
quantitative subscales
(paranoia, hallucinations,
cognitive disorganisation,
grandiosity, anhedonia,
negative symptoms): self-/
parent-rated
Twins Early Development
Study; N = 2152; age 16;
43% male
Individual SNP association.
28 genome-wide significant
schizophrenia-associated
SNPs with six quantitative PEs
Individual SNP
association. One SNP,
rs17512836, in TCF4
significantly associated (both
allelic and genotypic), after
correction for multiple testing,
with Paranoia PE subscale.
No significant associations for
other individual SNPs or with
other five PE subscales
Unweighted SNP composite
association. Association of
unweighted SNP score of
28 SNPs (as above) with six
quantitative PEs
Unweighted SNP composite
association. SNP composite
not significantly associated
with any PEs
PRS prediction.
Schizophrenia and bipolar
disorder PRS from the PGC
used to predict six
quantitative PEs
PRS prediction.
Schizophrenia and bipolar
disorder PRS did not
significantly predict higher PE
scores
Zammit et al.
(2013) [22]
Psychotic-like Symptoms
interview (PLIKSi),
11 questions on positive and
cognitive PEs, trained
interviewers. ‘Narrow’
categorical phenotype: one or
more definite PE at either age.
‘Broader’ phenotype: any
suspected or definite PEs
Avon Longitudinal Study of
Parents and Children;
N = 3483; age 12 and 18,
% male unknown
Individual SNP association.
17 genome-wide significant
schizophrenia-associated
SNPs with one or more
definite PE
Individual SNP
association. No significant
associations between
individual schizophrenia-
associated SNP risk alleles
and presence of one or more
definite PE after correction for
multiple testing
SNP composite
association. Association of
SNP score of same 17 SNPs
(as above) with one or more
definite PE
SNP composite
association. SNP composite
was not associated with
increased risk of one or more
definite PE
PRS prediction.
Schizophrenia PRS from PGC
used to predict presence of
one or more definite PE
PRS prediction. PRS did not
significantly predict presence
of one or more definite PE,
although on average
participants with at least one
definite PE had higher PRS
than those without
GWAS. Genome-wide
association study to identify
SNPs associated with
presence of one or more
definite PE
GWAS. None of 2.5 million
SNPs were genome-wide
significant ( p < 5  108).
SNPs with probable signals
( p < 5  105) not enriched
with variants associated with
schizophrenia from PGC
Same conclusions reached
with ‘broader’ PE phenotype
Note: GWAS, genome-wide association study; PE, psychotic experience; PGC, Psychiatric Genomics Consortium; SNP, single nucleotide
polymorphism; PRS, polygenic risk score.
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N = 3483 and a categorical assessment of PEs, this study
yielded no genome-wide significant loci [22]. On the
basis of the known effect sizes of common variants
associated with other complex traits, it is likely that a
GWAS of PEs requires a sample size of over 10,000
individuals to identify genome-wide significant loci [24].
Candidate gene studies
Candidate genes, most notably those related to activity of
the dopamine neurotransmitter, such as catechol-O-meth-
yltransferase (COMT), have been investigated in relation
to PEs with mixed results (e.g. [22,25]). A systematic
review of gene–environment interaction studies on candi-
date genes is available elsewhere [26]. Importantly, large-
scale projects underway will address some of the meth-
odological challenges in this type of research [27].
Environmental risk factors
Twin studies reviewed in Table 1 demonstrate that
nonshared, rather than shared, environment is important
in explaining variance in PEs. It is clear from estimates of
nonshared environment and the known measurement
error (estimated from test–retest reliability and internal
consistency values), that there is significant nonshared
environmental influence on PEs above and beyond var-
iance explained by measurement error, for example
[10]. In terms of the types of environments involved,
examples include cannabis use and stressful life events,
which have both been associated with PEs in young
people, for example [28,29]. Largely similar environmen-
tal risk factors are found for PEs as for psychotic disorders
[30].
Many apparent ‘environments’ are themselves partly
heritable, a process termed gene–environment correlation
[31]. For example, bullying victimisation, cannabis use
and stressful life events are all themselves partly heritable
[32–35]. To disentangle the role of nonshared environ-
ment from the impact of inherited genetic variation, the
strongest design is the discordant MZ twin design
[36,37]. If the twins with more PEs have had on average
more exposure to ‘environmental’ risk factors than their
genetically identical cotwins, this demonstrates an associ-
ation driven by nonshared environment. In addition,
gene–environment correlation analyses can be conducted
using twin data, where the heritability of ‘environmental’
variables such as cannabis use can be partitioned out, and
thus the role of the environment can be assessed inde-
pendent of heritability [2].
PEs and psychotic disorders: part of the same
severity continuum?
Do PEs and psychotic disorders such as schizophrenia lie
on the same severity continuum? There has been long
standing interest in the relationship between PEs and
clinical psychosis [38,39], see also [40]. This section
focuses on two new empirical findings that have tackled
this question using quantitative genetic designs.
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Figure 1
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In a recent study (Zavos et al.,
2014) [10], DeFries
Fulker analyses demonstrated
significant group heritability
for 15%, 10% and 5% most
extreme-scoring groups,
indicating a genetic link
between the extremes and
the rest of the sample for
psychotic experiences in 16-
year-olds. Liability threshold
models demonstrated no
significant change in
heritability in the extreme
groups compared to the
whole sample. This was
shown for quantitative self-
rated measures of paranoia
(shown in histogram),
hallucinations, cognitive
disorganisation, grandiosity,
anhedonia, and parent-rated
negative symptoms
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Histogram showing quantitative distribution of paranoia assessed in 16-year-olds.
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Recently it was shown that rates of mental illness in one
family member increased linearly across five groupings in
a general population sample of adults [41]. These five
groupings were based on ‘level’ of psychosis, varying from
no PEs and subclinical PEs, to ‘low’ or ‘high’ impact
psychotic symptoms and clinical psychotic disorder.
Prevalence of mental illness in multiple family members
increased extra-linearly across the five groups, suggesting
there was more than a linear increase in apparent genetic
risk (from the family information) with increasing PEs
across the spectrum of severity. This study covered the
full range of manifestations from no and few PEs all the
way to diagnosed psychotic disorders within the same
sample. It was limited by the fact that family history is not
a direct measure of genetic risk: family members also
provide environmental effects.
In a similar vein, new findings suggest that both mild and
infrequent PEs and severe and frequent PEs in the
general population in adolescence are part of the same
aetiological continuum [10] (see Figure 1). This study
demonstrates that heritability does not differ significantly
for high levels of PEs as for low or modest levels of PEs,
and that there appears to be a genetic link between high
and low levels of PEs [10]. This was shown using a
classic twin design, which is able to disentangle variance
into genetic and environmental influences and estimate
the net relative contributions of each. Because the sample
were in mid-adolescence however, it was not possible to
assess the genetic link between normal variation in PEs
and diagnosed psychotic disorders, since the sample was
too young to ascertain who would receive a diagnosis: the
most severe group were defined as the highest-scoring 5%
of the sample. These studies bring new approaches to the
old question of how PEs relate to diagnosed psychotic
disorders such as schizophrenia [38].
Conclusion
This brief review focuses on new quantitative genetic
investigations of PEs over the last four years. It has shown
how new approaches have tackled old questions regarding
the relative role of genes and environment on PEs and
how PEs relate to diagnosed psychotic disorders such as
schizophrenia.
New findings on adolescence [10,20,22] are advan-
tageous because adolescence is before the typical age of
onset of most cases of psychotic disorder, and PEs are
common in this age group. Quantitative genetic research
on PEs in adolescence may be particularly informative for
identifying the causes underlying the precursors of psy-
chotic illness and showing what leads PEs to be transitory
or persistent.
Caution is needed in this field not to mislabel normal
variation in PEs in the general population as psychiatric
illness [42]. Evidence for or against psychotic illness
being on a continuum with PEs does not change the
practical need for categorical definitions of psychiatric
illness [43]. Vice versa, because there is clinical need for
categorical definitions, this should not prevent research-
ers exploring the causes of PEs dimensionally, given that
they exist dimensionally in the population (see Figure 1).
Another improvement has been research on specific indi-
vidual PEs, which brings greater clarity to what causes
individual experiences such as paranoia, hallucinations,
and negative symptoms individually, rather than assum-
ing that PEs form part of a single construct, which is
in opposition to empirical psychometric evidence
[3,12,44,45]. Going forward, it is unrealistic to expect a
one-to-one mapping between PEs and schizophrenia, or
to find large effect sizes between PEs and schizophrenia,
in light of the heterogeneity inherent in the latter. There
is much anticipation to understand the origins of PEs as
normal aspects of life, particularly in young people, and as
predictors of clinically relevant psychopathology.
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